ArticleJournal of medical systems2025
An Interpretable Hybrid AI Model for Breast Fine Needle Aspiration Cytology Image Classification.
Article in Journal of medical systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While Fine needle aspiration cytology (FNAC) and mammography are both used to diagnose breast lesions, FNAC is generally more accurate than mammograms for predicting breast cancer. It is also gaining popularity as an early detection tool due to its rapid and straightforward procedure, cost-effectiveness, and minimal risk of complications. Deep learning enhances breast cancer detection by extracting crucial features, yielding highly accurate results compared to conventional techniques. Classical machine learning is less time-intensive and requires fewer parameter adjustments. This work is presented as a proof-of-concept study on FNAC images obtained from two centers. It explores eighteen hybrid architectures that are developed and evaluated, combining the strength of deep learning techniques- Inception-V3, MobileNet-V2, and DenseNet-121 for feature extraction, with three machine learning classifiers (Support Vector Machine, Decision Tree, and k-Nearest Neighbours) for binary classification of fine needle aspiration cytology images of the breast. Our study is based on an indigenously collected dataset of 427 images (152 benign and 275 malignant), which was later expanded through augmentation to 2,866 images (1216 benign and 1,650 malignant). The hybrid model, which combines feature extraction from MobileNet-V2 and DenseNet-121 in a concatenated architecture, achieves the highest internal test accuracy of 98.26% when paired with an SVM classifier. It also achieves the best-known sensitivity (97.95%) and specificity (98.48%). The explainability model, which utilizes Grad-CAM, achieved 95% positive clinical validation by expert pathologists, underscoring the model's trustworthiness and interpretability-critical for clinical adoption and decision-making support. The proposed hybrid model, with its impressive metrics and validation rate, underscores the model's ability to provide clear, interpretable insights that support clinical decision-making.
Indexed as
Identifiers
41381926What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.